{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/67c5d757b48a8f157c1f9076/69f1d173526757e10b9e5b09?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"LMFM Presenter Opens Up about Prostate Cancer Experience as New All-Island Radiotherapy Trial Launch Approaches - 29/04/2026","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/67c5d757b48a8f157c1f9076/1777451588263-4ae30389-cd0e-4179-8780-e53c5198a62d.jpeg?height=200","description":"<p>A major new all-island radiotherapy trial, INSPIRE, will launch this Spring.</p><p><br></p><p>Sponsored by Cancer Trials Ireland, and supported by the Irish Research Radiation Oncology Group, the study aims to reduce treatment side-effects while maintaining excellent cancer control for men with prostate cancer.</p><p><br></p><p>With more than 5,000 men diagnosed with prostate cancer across the island of Ireland each year, there is a clear need to continue improving treatment and reducing its impact on quality of life. The trial plans to recruit more than 130 patients across Ireland.&nbsp;</p><p><br></p><p>The INSPIRE trial is for men with localised prostate cancer who are suitable for treatment with Stereotactic Ablative Radiotherapy (SABR).</p><p><br></p><p>We were joined on The Agenda this morning by Angela Clayton-Lea, CEO of Cancer Trials Ireland &amp; Ashbourne native, who told us more about this.</p><p><br></p><p>We were also joined by Martin Sweeney, who was diagnosed with prostate cancer and was involved in the design of the trials.</p><p><br></p><p><br></p>","author_name":"lmfm "}